MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, IMCR has $1,102,500K in assets. $705,936K in debts. $498,413K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
600.43%
Quick Ratio
597.11%
Cash Ratio
292.58%
Debt to Asset Ratio
64.03%
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Interest-bearing loans and borro...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
498,413 487,933
Marketable securities
393,940 394,878
Accounts receivable, net
75,880 69,761
Prepaid expenses and other current assets
48,960 44,270
Inventory, net
5,655 5,456
Total current assets
1,022,848 1,002,298
Property and equipment, net
9,433 9,548
Operating lease right of use assets, net
39,397 39,428
Deferred tax assets, net
14,333 14,077
Other non-current assets
16,489 17,036
Total assets
1,102,500 1,082,387
Accounts payable
22,956 23,856
Accrued expenses and other current liabilities
144,937 143,785
Deferred revenue, current
582 594
Operating lease liabilities, current
1,878 1,843
Total current liabilities
170,353 170,078
Accrued expenses, non-current
96,604 83,960
Deferred revenue, non-current
4,995 5,247
Operating lease liabilities, non-current
41,397 42,561
Interest-bearing loans and borrowings
392,587 392,060
Total liabilities
705,936 693,906
Ordinary shares (voting and non-voting), 0.002 par value, most recent authority to allot up to a maximum nominal value of 149,633 and 97,454 shares as of september30, 2025 and december31, 2024, respectively, and 50,467,954 and 50,064,860 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively
135 135
Deferred shares, 0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of september30, 2025 and december31, 2024
1 1
Additional paid-in capital
1,227,649 1,215,997
Accumulated deficit
-801,215 -801,038
Accumulated other comprehensive loss
-30,006 -26,614
Total shareholders' equity
396,564 388,481
Total liabilities and shareholders' equity
1,102,500 1,082,387
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventory, net$5,655K Prepaid expenses andother current assets$48,960K Accounts receivable, net$75,880K Marketable securities$393,940K Cash and cashequivalents$498,413K Other non-currentassets$16,489K Deferred tax assets, net$14,333K Operating lease right ofuse assets, net$39,397K Property and equipment,net$9,433K Total current assets$1,022,848K Total assets$1,102,500K Total liabilities andshareholders' equity$1,102,500K Total shareholders'equity$396,564K Total liabilities$705,936K Accumulated othercomprehensive loss-$30,006K Accumulated deficit-$801,215K Additional paid-in capital$1,227,649K Interest-bearing loans andborrowings$392,587K Operating leaseliabilities, non-current$41,397K Deferred revenue,non-current$4,995K Accrued expenses,non-current$96,604K Total currentliabilities$170,353K Deferred shares, 0.0001par value,...$1K Ordinary shares (votingand non-voting),...$135K Operating leaseliabilities, current$1,878K Deferred revenue,current$582K Accrued expenses andother current...$144,937K Accounts payable$22,956K

Immunocore Holdings plc (IMCR)

Immunocore Holdings plc (IMCR)